Statistics
Publications
2
Citations
50
H-Index
2
Active since
2015
Affiliations
Hubei University of Chinese Medicine(Current)
Zhang Chi-zhi is an author at Hubei University of Chinese Medicine.
Publications per year
2015–2019
2
2
Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expression.
Zhang Chi-zhi, Xiaodong Wang, Hongwei Wang et al. · PubMed · 2015 · 32 citations
1–2 of 2